| Serial Number | 86382988 |
| Word Mark | ORBIS BIOSCIENCES |
| Filing Date | Tuesday, September 2, 2014 |
| Status | 702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED |
| Status Date | Tuesday, July 6, 2021 |
| Registration Number | 4869227 |
| Registration Date | Tuesday, December 15, 2015 |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, September 29, 2015 |
| Disclaimer with Predetermined Text | "BIOSCIENCES" |
| Goods and Services | Manufacturing services for others in the area of pharmaceutical drug delivery systems, including continuous release, pulsatile release, extended release, sustained release, taste masked release, and delayed release systems, clinical manufacturing of drug formulations for others to support clinical trials, fabrication and preparation of active pharmaceutical ingredients for others, technology scale-up services for others, and integration of technology into manufacturing processes for others, all relating to multiple drug product formats, namely, semi-solids, solutions, suspensions, particulates, solid dispersions, solid solutions and injectables |
| Goods and Services | Pharmaceutical drug delivery technology development services; pharmaceutical drug delivery technology development services, namely, research and development in the area of pharmaceutical drug delivery systems, including continuous release, pulsatile release, extended release, sustained release, taste masked release, and delayed release systems, consisting of selection of drug formulation and delivery systems to optimize performance of active pharmaceutical ingredients, analytic techniques to test drug formulations, analytic services to detect, identify and quantify drug components, stability testing, physical characterizations of formulations, in-vitro release testing, all relating to multiple drug product formats, namely, semi-solids, solutions, suspensions, particulates, solid dispersions, solid solutions and injectables |
| Pseudo Mark | ORBIS BIO SCIENCES |
| International Class | 040 - Treatment of materials. |
| US Class Codes | 100, 103, 106 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, June 16, 2015 |
| Primary Code | 040 |
| First Use Anywhere Date | Thursday, September 4, 2008 |
| First Use In Commerce Date | Thursday, September 4, 2008 |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, September 12, 2014 |
| Primary Code | 042 |
| First Use Anywhere Date | Thursday, September 4, 2008 |
| First Use In Commerce Date | Thursday, September 4, 2008 |
| Party Name | Adare Pharmaceuticals USA, Inc. |
| Party Type | 31 - New Owner After Registration |
| Legal Entity Type | 03 - Corporation |
| Address | Lawrenceville, NJ 08648 |
| Party Name | Orbis Biosciences, Inc. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | Kansas City, KS 66103 |
| Party Name | Orbis Biosciences, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Kansas City, KS 66103 |
| Party Name | Orbis Biosciences, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Kansas City, KS 66103 |
| Event Date | Event Description |
| Tuesday, July 6, 2021 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED |
| Tuesday, July 6, 2021 | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. |
| Tuesday, July 6, 2021 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| Tuesday, February 23, 2021 | TEAS SECTION 8 & 15 RECEIVED |
| Tuesday, December 15, 2020 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
| Wednesday, October 14, 2020 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| Wednesday, October 7, 2020 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| Tuesday, April 26, 2016 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Tuesday, April 26, 2016 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Tuesday, December 15, 2015 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, September 29, 2015 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, September 29, 2015 | PUBLISHED FOR OPPOSITION |
| Wednesday, September 9, 2015 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Wednesday, August 26, 2015 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Wednesday, August 26, 2015 | ASSIGNED TO LIE |
| Saturday, August 8, 2015 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Friday, August 7, 2015 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, August 7, 2015 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, August 7, 2015 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
| Wednesday, July 1, 2015 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Wednesday, July 1, 2015 | FINAL REFUSAL E-MAILED |
| Wednesday, July 1, 2015 | FINAL REFUSAL WRITTEN |
| Tuesday, June 16, 2015 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, June 15, 2015 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, June 15, 2015 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, December 19, 2014 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Friday, December 19, 2014 | NON-FINAL ACTION E-MAILED |
| Friday, December 19, 2014 | NON-FINAL ACTION WRITTEN |
| Monday, December 15, 2014 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, December 15, 2014 | NON-FINAL ACTION E-MAILED |
| Monday, December 15, 2014 | NON-FINAL ACTION WRITTEN |
| Sunday, December 14, 2014 | ASSIGNED TO EXAMINER |
| Saturday, September 13, 2014 | NOTICE OF PSEUDO MARK E-MAILED |
| Friday, September 12, 2014 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| Friday, September 5, 2014 | NEW APPLICATION ENTERED IN TRAM |